Estrogen-Dependent Cancers: What They Are, Causes, and How They're Treated

Oct 8

7 min read

Updated: 2 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 17, 2026

Quick Answer

Estrogen-dependent cancers are cancers that use estrogen to grow and possibly spread [4]. They include breast, ovarian, and uterine (endometrial) cancers [4]. Estrogen is not thought to directly start most cancers, but long-term exposure raises the risk of some, and it makes some cancerous cells grow faster when it binds to receptors in the cells [4]. [1] [4]. Hormone therapy is a common treatment [4].

What the research says

Every extra year of ovarian hormone exposure counts. In an analysis of 117 studies including 118,964 women with breast cancer and 306,091 without (none had used menopausal hormone therapy), breast cancer risk rose by 5.0% for every year younger at menarche (RR 1.050, 95% CI 1.044–1.057) and by 2.9% for every year older at menopause (RR 1.029, 95% CI 1.025–1.032). The menopause effects were stronger for estrogen receptor-positive than receptor-negative disease (PubMed: Collaborative Group on Hormonal Factors in Breast Cancer, Lancet Oncol, 2012 [1]).
Hormone therapy lowers deaths from receptor-positive breast cancer. In a patient-level meta-analysis of 31,920 postmenopausal women with ER-positive early breast cancer, 5 years of an aromatase inhibitor lowered 10-year breast cancer mortality compared with 5 years of tamoxifen (12.1% vs 14.2%; RR 0.85). There were fewer endometrial cancers with aromatase inhibitors (10-year incidence 0.4% vs 1.2%) but more bone fractures (5-year risk 8.2% vs 5.5%) (PubMed: EBCTCG, Lancet, 2015 [2]).
Tamoxifen's effect on the uterus is real but should be weighed against its benefits. A systematic review and dose-response meta-analysis of 26 studies found that tamoxifen use in women with breast cancer was associated with about double the risk of endometrial cancer (RR 2.03, 95% CI 1.68–2.45), with risk rising as dose and duration increased (PubMed: Ghanavati et al., Cancer Rep, 2023 [3]).

What Are Estrogen-Dependent Cancers?

Estrogen-dependent cancers use the female estrogen hormone to grow and possibly spread [4]. Estrogen doesn't directly start most cancers, but long-term exposure raises the risk of some, and it can make some cancerous cells grow more quickly [4]. This happens when estrogen attaches to proteins (receptors) in cancerous cells [4].

Breast, ovarian, and uterine (endometrial) cancers are examples of estrogen-dependent cancers [4]. Oncologists treat these cancers with hormone therapy that keeps estrogen away from cancerous cells [4].

Key point	What it means
Role of estrogen	Estrogen doesn't cause cancer, but it can make some cancerous cells grow more quickly [4]
How it works	Estrogen attaches to proteins (receptors) inside cancerous cells [4]
Common types	Breast, ovarian, and uterine (endometrial) cancers
Most common example	Breast cancer
Main treatment	Hormone therapy that keeps estrogen away from cancerous cells [4]
Main risk driver	Long-term exposure to estrogen over your lifetime [4]

Infographic titled Estrogen-Dependent Cancers: At a Glance showing estrogen attaching to receptors on a cancer cell, the three main types (breast cancer, the most common; ovarian cancer; uterine or endometrial cancer), and three key points: estrogen doesn't cause cancer but fuels growth, long-term exposure raises risk, and hormone therapy treats it – rinnit.com — Figure 1: Estrogen-dependent cancers at a glance.

Types of Estrogen-Dependent Breast Cancer

Breast cancer is the most common example of an estrogen-dependent cancer [4]. Estrogen plays a role in several types [4].

Breast cancer type	Connection to estrogen
ER-positive (ER+) breast cancer	Estrogen receptors fuel the cancer's growth [4]
HR-positive (HR+) breast cancer	Hormone receptors (estrogen, progesterone, or both) fuel the cancer [4]
Luminal A breast cancer	An estrogen-driven breast cancer subtype
Luminal B breast cancer	An estrogen-driven breast cancer subtype
Triple positive breast cancer	Tests positive for estrogen, progesterone, and HER2 receptors

By contrast, triple-negative breast cancer does not depend on these receptors.

What Causes Estrogen-Dependent Cancer?

This type of cancer happens when estrogen attaches to cancerous cells in certain parts of the body [4]. Some cells in the body have proteins (hormone receptors). Estrogen in the bloodstream can attach to the proteins [4]. In healthy cells, estrogen that attaches to proteins helps those cells work and grow [4]. In estrogen-dependent cancer, the hormone makes cancerous cells divide and multiply [4].

Risk factors

Long-term exposure to the hormone increases your risk [4]. Long-term exposure may happen in the following ways:

Long-term exposure scenario	Detail
Early periods	Starting your period before age 12 [4]
Late menopause	Going into menopause after 55 [4]
Menopause hormone therapy	Taking hormone replacement therapy for menopause symptoms
Estrogen-only therapy	Taking estrogen-only hormonal replacement therapy for a long time can increase the risk that ovarian cancer will be estrogen-dependent [4]
Estrogen dominance	Having a hormone imbalance [4]

Other risk factors include having obesity and having polycystic disease [4].

Rarely, taking the cancer drug tamoxifen (a selective estrogen receptor modulator) for breast cancer may increase your risk of estrogen-dependent uterine cancer [3] [4]. Tamoxifen lowers breast cancer risk and treats hormone-positive breast cancer that comes back [4]. But if you're going through menopause, the drug acts like estrogen and helps uterine cancer grow [4].

Infographic titled Estrogen-Dependent Cancer: Causes and Risk Factors comparing a healthy cell, where estrogen helps cells work and grow, with an estrogen-dependent cancer cell, where it makes cells divide and multiply, plus eight long-term exposure risk factors and a note on tamoxifen – rinnit.com — Figure 2: Causes and risk factors of estrogen-dependent cancers.

How Is Estrogen-Dependent Cancer Diagnosed?

Your healthcare provider or oncologist will do a biopsy to get tissue samples [4]. A lab checks the samples for hormone receptors [4]. A hormone receptor-positive (HR+) result means estrogen, progesterone, or both hormones are helping cancer to grow [4].

Test step	What it involves
Biopsy	The provider or oncologist obtains tissue samples [4]
Lab analysis	The lab checks the samples for hormone receptors [4]
HR+ result	Means estrogen, progesterone, or both hormones are helping cancer to grow [4]

Treatment for Estrogen-Dependent Cancer

Hormone therapy for cancer is a common treatment for estrogen-dependent cancer [4] (for example, aromatase inhibitors in breast cancer [2]). Your oncologist may use hormone therapy with other treatments, like surgery, chemotherapy, or radiation therapy [4].

How hormone therapy works

How it works	What happens
Blocks estrogen access	The therapy blocks cancerous cells' access to estrogen [4]
Stops estrogen production	The therapy keeps your body from producing estrogen [4]
Replaces with lab-made estrogen	The therapy replaces estrogen with lab-made hormone that cancer can't use to grow [4]

Infographic titled Diagnosing and Treating Estrogen-Dependent Cancers showing biopsy, lab testing for hormone receptors and the HR-positive result, the three ways hormone therapy works, and combination with surgery, radiation, or chemotherapy – rinnit.com — Figure 3: Diagnosing and treating estrogen-dependent cancers.

Phytoestrogens and Estrogen-Dependent Cancer Risk

Can I reduce my risk by avoiding phytoestrogens?

Researchers are unsure if phytoestrogen affects your risk of estrogen-dependent cancers [4]. Phytoestrogens are plant-based foods that act like estrogen [4]. Soy, flaxseed and whole grains are examples [4]. Research shows that getting estrogen from food may be useful if you have low estrogen levels [4]. It may be a different story if you don't need extra estrogen.

Key Takeaways

Estrogen is an essential female hormone. It supports the reproductive system and helps the body work in different ways. But this essential hormone can become the engine that fuels certain types of cancers. If you have breast cancer, endometrial cancer, or ovarian cancer, your oncologist may do tests to see if estrogen is making cancer grow more quickly. That way, they can recommend the treatment that's right for you.

If you've been diagnosed with breast, endometrial, or ovarian cancer, ask your oncologist whether the cancer is hormone receptor-positive. If it is, hormone therapy may be part of your treatment plan.

Take the Next Step

If you have long-term estrogen exposure risk factors — such as early periods, late menopause, or ongoing hormone replacement therapy — talk to your healthcare provider about your individual risk.

Further reading: American Cancer Society — Breast Cancer Hormone Receptor Status · National Cancer Institute — Hormone Therapy for Breast Cancer · National Cancer Institute — Risk Factors: Hormones · Phytoestrogens and Health Effects (Nutrients)

Frequently Asked Questions

1. What are estrogen-dependent cancers?

Estrogen-dependent cancers are cancers that use the estrogen hormone to grow and possibly spread. Breast, ovarian, and uterine (endometrial) cancers are examples. Breast cancer is the most common. Oncologists treat these cancers with hormone therapy that keeps estrogen away from cancerous cells.

2. Does estrogen cause cancer?

Not directly in most cases, but long-term estrogen exposure raises the risk of some cancers, and it can make some cancerous cells grow more quickly when it attaches to proteins (receptors) in cancerous cells. In healthy cells, estrogen helps cells work and grow; in estrogen-dependent cancer, it makes cancerous cells divide and multiply.

3. What are the risk factors for estrogen-dependent cancers?

Long-term exposure to estrogen increases risk. This includes starting your period before age 12, going into menopause after 55, taking hormone replacement therapy for menopause symptoms, long-term estrogen-only therapy, estrogen dominance, obesity, and polycystic disease.

4. What are estrogen-dependent breast cancer types?

Estrogen plays a role in ER-positive (ER+) breast cancer, HR-positive (HR+) breast cancer, Luminal A breast cancer, Luminal B breast cancer, and triple positive breast cancer. Breast cancer is the most common estrogen-dependent cancer.

5. How is estrogen-dependent cancer diagnosed?

A healthcare provider or oncologist does a biopsy to get tissue samples. A lab checks the samples for hormone receptors. A hormone receptor-positive (HR+) result means estrogen, progesterone, or both hormones are helping the cancer to grow.

6. How does hormone therapy treat estrogen-dependent cancer?

Hormone therapy works by blocking cancerous cells' access to estrogen, keeping the body from producing estrogen, or replacing estrogen with lab-made hormone that cancer can't use to grow. Oncologists may combine it with surgery, chemotherapy, or radiation therapy.

7. Can hormone replacement therapy increase cancer risk?

Taking hormone replacement therapy for menopause symptoms is a risk factor for estrogen-dependent cancers because it extends estrogen exposure. Long-term estrogen-only hormone replacement therapy can also increase the risk that ovarian cancer will be estrogen-dependent.

8. Can tamoxifen increase the risk of estrogen-dependent cancer?

Rarely, taking the cancer drug tamoxifen for breast cancer may increase the risk of estrogen-dependent uterine cancer. Tamoxifen lowers breast cancer risk and treats hormone-positive breast cancer that comes back, but during menopause the drug acts like estrogen and can help uterine cancer grow.

9. Do phytoestrogens affect the risk of estrogen-dependent cancers?

Researchers are unsure. Phytoestrogens are plant-based foods that act like estrogen — examples include soy, flaxseed and whole grains. Food-based estrogen may be useful if you have low estrogen levels, but may be different if you don't need extra estrogen.

10. What cancers are examples of estrogen-dependent cancers?

Breast, ovarian, and uterine (endometrial) cancers are examples of estrogen-dependent cancers. Breast cancer is the most common example.

References

Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141-1151. doi:10.1016/S1470-2045(12)70425-4. PMID: 23084519.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341-1352. doi:10.1016/S0140-6736(15)61074-1. PMID: 26211827.
Ghanavati M, Khorshidi Y, Shadnoush M, et al. Tamoxifen use and risk of endometrial cancer in breast cancer patients: a systematic review and dose-response meta-analysis. Cancer Rep (Hoboken). 2023;6(4):e1806. doi:10.1002/cnr2.1806. PMID: 36916539.
Cleveland Clinic. Estrogen-dependent cancers. Cleveland Clinic Health Library. Medically reviewed; last updated September 2, 2025. https://my.clevelandclinic.org/health/diseases/10312-estrogen-dependent-cancers

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.